chr4-1349646-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_020894.4(UVSSA):āc.221A>Gā(p.Gln74Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000496 in 1,614,100 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_020894.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000217 AC: 33AN: 152186Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.0000558 AC: 14AN: 250872Hom.: 0 AF XY: 0.0000663 AC XY: 9AN XY: 135814
GnomAD4 exome AF: 0.0000322 AC: 47AN: 1461796Hom.: 0 Cov.: 34 AF XY: 0.0000303 AC XY: 22AN XY: 727206
GnomAD4 genome AF: 0.000217 AC: 33AN: 152304Hom.: 1 Cov.: 33 AF XY: 0.000215 AC XY: 16AN XY: 74472
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 27, 2021 | The c.221A>G (p.Q74R) alteration is located in exon 3 (coding exon 2) of the UVSSA gene. This alteration results from a A to G substitution at nucleotide position 221, causing the glutamine (Q) at amino acid position 74 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at